SMMT
SMMT
US86627T1088
Summit Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
1.094.374.000 210.977.000
418.7%
Operating Income -1.094.374.000 -210.977.000
418.7%
Pretax Income -1.079.536.000 -221.301.000
387.8%
Net Income Common Stockholders -1.079.586.000 -221.315.000
387.8%
-- --
--
-- --
--
ende